Effects of indomethacin and iloprost on contraction of the afferent arterioles by endothelin-1 in juxtamedullary nephron preparations from normotensive Wistar-Kyoto and spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology
M R GonzálezC F Sánchez-Ferrer

Abstract

The contractile effects of endothelin-1 on the afferent arterioles of normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR) and the modulation of these responses by cyclooxygenase blockade or by the prostacyclin analog iloprost were investigated. For this, the preglomerular vasculature was visualized by using the juxtamedullary nephron preparation. Endothelin-1 (100 pM-1 microM) induced concentration-dependent reduction of afferent diameters either in WKY and SHR kidneys, which were inhibited by 1 microM nifedipine, indicating its dependence on extracellular calcium. After incubation with 20 microM indomethacin, the endothelin-1-induced contractions were potentiated in WKY but abolished in SHR vessels. These results could be explained if endothelin-1 is releasing vasodilator prostanoids in WKY, whereas in SHR preparations, vasoconstrictor prostanoids predominate. The prostacyclin analog iloprost (1 nM-1 microM) did not modify basal diameters of the WKY afferent arterioles, whereas a weak vasodilatatory effect was observed in the SHR afferent vasculature. Both in WKY and SHR preparations, iloprost (10 nM-1 microM) abolished the afferent contractility by endothelin-1, this effect being more prominent in SHR. W...Continue Reading

References

Sep 1, 1992·The American Journal of Physiology·M Colden-StanfieldE K Gallin
May 1, 1992·The Journal of Clinical Investigation·N Bank, H S Aynedjian
May 1, 1991·Renal Physiology and Biochemistry·M FretschnerM Steinhausen
Dec 1, 1991·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·E VillaR García-Robles
Feb 1, 1992·Hypertension·M F O'Rourke
Jun 1, 1990·British Journal of Pharmacology·J Quilley, J C McGiff
Dec 1, 1989·Journal of Cardiovascular Pharmacology·P MadedduV Anania
Oct 24, 1989·European Journal of Pharmacology·K MiuraK Yamamoto
Jun 1, 1989·The American Journal of Physiology·S J KingS Oparil
Apr 12, 1989·European Journal of Pharmacology·A López-FarréJ M López-Novoa
Apr 1, 1989·Circulation Research·C F Sanchez-FerrerD R Harder
Jan 1, 1993·Journal of Cardiovascular Pharmacology·P D'Orléans-JusteS Télémaque
Jul 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S Y Chou, J G Porush
Aug 10, 1995·The New England Journal of Medicine·E R Levin
Sep 1, 1994·British Journal of Pharmacology·J J MaguireA P Davenport
Nov 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F R DeRubertis, P A Craven

❮ Previous
Next ❯

Citations

Aug 10, 2004·Clinical and Experimental Pharmacology & Physiology·Kate M DentonRoger G Evans
Nov 30, 2000·American Journal of Physiology. Renal Physiology·J D Imig

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Armin JustWilliam J Arendshorst
Hypertension
Hui-Fang Cheng, Raymond C Harris
Proceedings of the National Academy of Sciences of the United States of America
S OffermannsG Schultz
© 2021 Meta ULC. All rights reserved